Legend Biotech Corporation (LEGN)
USD 33.97
(-2.05%)
USD 33.97
(-2.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 285.14 Million | 117 Million | 89.79 Million | 75.67 Million | 57.26 Million | 49.13 Million |
| Cost of Revenue | 144.21 Million | 65.36 Million | 313.34 Million | 232.16 Million | - | - |
| Gross Profit | 140.92 Million | 51.64 Million | -223.55 Million | -156.48 Million | 57.26 Million | 49.13 Million |
| Operating Expenses | 583.14 Million | 509.69 Million | 462.82 Million | 304.87 Million | 192.63 Million | 64.2 Million |
| Selling, General and Administrative Expenses | 200.92 Million | 174.04 Million | 149.48 Million | 72.71 Million | 32.37 Million | 3.92 Million |
| Research and Development Expenses | 382.21 Million | 335.64 Million | 313.34 Million | 232.16 Million | 161.94 Million | 60.63 Million |
| Other Expenses | - | 2.22 Million | -6.07 Million | -74.21 Million | -1.68 Million | -2000.00 |
| Cost and Expenses | 727.35 Million | 575.05 Million | 462.82 Million | 304.87 Million | 192.63 Million | 64.2 Million |
| Operating Income | -439.48 Million | -455.82 Million | -393.02 Million | -313.34 Million | -130.87 Million | -1.53 Million |
| Interest Expense | 21.79 Million | 10.79 Million | 900 Thousand | 4.2 Million | 223 Thousand | 82 Thousand |
| Income Tax Expense | -1.86 Million | 625 Thousand | 1000.00 | -4.14 Million | 2.6 Million | 1.16 Million |
| Earnings before Tax | -520.11 Million | -445.72 Million | -386.2 Million | -307.62 Million | -130.37 Million | -1.61 Million |
| Net Income | -518.25 Million | -446.34 Million | -386.2 Million | -303.47 Million | -132.97 Million | -2.78 Million |
| Earnings Per Share Basic | -2.94 | -2.81 | -2.74 | -2.57 | -1.01 | -0.03 |
| Earnings Per Share Diluted | -2.94 | -2.81 | -2.74 | -2.57 | -1.01 | -0.03 |
| Weighted Average Shares Outstanding | 176.08 Million | 159.04 Million | 140.85 Million | 118.15 Million | 132 Million | 100 Million |
| Weighted Average Shares Outstanding (Diluted) | 176.08 Million | 159.04 Million | 140.85 Million | 118.15 Million | 132 Million | 100.21 Million |
| Gross Margin | 0.49 | 0.44 | -2.49 | -2.07 | 1.00 | 1.00 |
| EBIT Margin | -1.68 | -3.74 | -4.22 | -4.01 | -2.19 | -0.15 |
| Profit Margin | -1.82 | -3.81 | -4.30 | -4.01 | -2.32 | -0.06 |
| EBITDA | -477.87 Million | -416.53 Million | -392.37 Million | -294.14 Million | -124.88 Million | 149 Thousand |
| Earnings Before Tax Margin | -1.54 | -3.90 | -4.38 | -4.14 | -2.29 | -0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 186.52 Million | 93.99 Million | 285.14 Million | 79.46 Million | 96.01 Million | 73.33 Million |
| Cost of Revenue | 55.82 Million | 60.46 Million | 164.66 Million | 37.8 Million | 43.47 Million | 32.67 Million |
| Gross Profit | 130.7 Million | 33.53 Million | 120.47 Million | 41.66 Million | 52.53 Million | 40.65 Million |
| Operating Expenses | 172.67 Million | 151.39 Million | 562.69 Million | 162.71 Million | 144.88 Million | 143.62 Million |
| Selling, General and Administrative Expenses | 60.04 Million | 50.43 Million | - | 57.03 Million | 49.2 Million | 49.18 Million |
| Research and Development Expenses | 112.62 Million | 100.96 Million | - | 105.68 Million | 95.85 Million | 95.79 Million |
| Other Expenses | 615 Thousand | -440 Thousand | -28.23 Million | -28.17 Million | 6.93 Million | -4.46 Million |
| Cost and Expenses | 228.49 Million | 211.85 Million | 727.35 Million | 200.51 Million | 188.36 Million | 176.29 Million |
| Operating Income | -41.97 Million | -117.86 Million | -442.21 Million | -121.05 Million | -66.99 Million | -88.65 Million |
| Interest Expense | 5.48 Million | 5.47 Million | 21.79 Million | 5.82 Million | 5.67 Million | 5.18 Million |
| Income Tax Expense | 226 Thousand | 5000.00 | -1.86 Million | -1.99 Million | -288 Thousand | 290 Thousand |
| Earnings before Tax | -17.97 Million | -59.78 Million | -520.11 Million | -146.81 Million | -62.49 Million | -198.83 Million |
| Net Income | -18.19 Million | -59.79 Million | -518.25 Million | -144.81 Million | -62.2 Million | -199.12 Million |
| Earnings Per Share Basic | -0.10 | -0.33 | - | -0.80 | -0.34 | -1.14 |
| Earnings Per Share Diluted | -0.10 | -0.33 | - | -0.80 | -0.34 | -1.14 |
| Weighted Average Shares Outstanding | 182.6 Million | 182 Million | 176.08 Million | 181.91 Million | 181.78 Million | 175.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 182.6 Million | 182 Million | 176.08 Million | 181.91 Million | 181.78 Million | 175.25 Million |
| Gross Margin | 0.70 | 0.36 | 0.42 | 0.52 | 0.55 | 0.55 |
| EBIT Margin | -0.20 | -1.19 | - | -1.46 | -0.64 | -1.21 |
| Profit Margin | -0.10 | -0.64 | -1.82 | -1.82 | -0.65 | -2.72 |
| EBITDA | -36.6 Million | -112.14 Million | - | -115.7 Million | -61.82 Million | -88.65 Million |
| Earnings Before Tax Margin | -0.23 | -1.25 | -1.55 | -1.52 | -0.70 | -1.21 |
600649
HWAL
COPEC
MEDICAMEQ
3880
BHC